Download Product Catalogue

Product Detail

OCTREOKAL-50

Octreokal-50

Octreotide 50mcg Injection

Acromegaly (overproduction of growth hormone). Carcinoid tumor management (to decrease flushing and diarrhea). 

Acromegaly (overproduction of growth hormone). Carcinoid tumor management (to decrease flushing and diarrhea). Vasoactive intestinal peptide-secreting tumor (VIPoma) control. Applied to avoid post-pancreatic surgery complications. Management of esophageal varices bleeding in cirrhosis.

MRP: ₹345/-
Send Enquiry

100%

Certified Products

Secure

pAYMENTS

24/7

Customer Support

100%

Certified Products

Secure

PAYMENTS

24/7

Customer Support

About The Product

Uses

Acromegaly (overproduction of growth hormone). Carcinoid tumor management (to decrease flushing and diarrhea). Vasoactive intestinal peptide-secreting tumor (VIPoma) control. Applied to avoid post-pancreatic surgery complications. Management of esophageal varices bleeding in cirrhosis.

Side Effects

  • Pain, redness or swelling of injection site Nausea, vomiting, cramps in the abdomen Diarrhea or constipation Gallstones (long term use) Headache, dizziness Disturbed levels of blood sugar (hypoglycemia or hyperglycemia)

Uses

Acromegaly (overproduction of growth hormone). Carcinoid tumor management (to decrease flushing and diarrhea). Vasoactive intestinal peptide-secreting tumor (VIPoma) control. Applied to avoid post-pancreatic surgery complications. Management of esophageal varices bleeding in cirrhosis.

Side Effects

  • Pain, redness or swelling of injection site Nausea, vomiting, cramps in the abdomen Diarrhea or constipation Gallstones (long term use) Headache, dizziness Disturbed levels of blood sugar (hypoglycemia or hyperglycemia)

Indications

  • Acromegaly (where surgery/radiotherapy is inappropriate or as additional treatment). Functional gastroenteropancreatic endocrine tumors (carcinoid, VIPoma, glucagonoma, gastrinoma, insulinoma) symptomatic treatment. Treatment of acute hemorrhage of gastroesophageal varices (endoscopic treatment).

FAQ

Q1. What is the use of OCTREOKAL-50?
It is primarily applied to the treatment of acromegaly and hormone-secreting tumors, and to the management of severe diarrhea and flushing due to tumors.

Q2. Is it applicable in bleeding varices?
Octreotide, yes, is useful in controlling bleeding esophageal varices, typically in combination with endoscopic procedures.

Q3. Is it safe to diabetics?
It should be used with caution since it can influence blood sugar. Regular monitoring of blood glucose should be done.

Q4. In what way is it given?
It is injected by a medical practitioner through subcutaneous injection or intravenous infusion.

Q5. Is there a problem with long-term use?
Yes, there is a risk of developing gallstones or digestive disturbances, with long-term use, and it is important to monitor.

Indications

  • Acromegaly (where surgery/radiotherapy is inappropriate or as additional treatment). Functional gastroenteropancreatic endocrine tumors (carcinoid, VIPoma, glucagonoma, gastrinoma, insulinoma) symptomatic treatment. Treatment of acute hemorrhage of gastroesophageal varices (endoscopic treatment).

FAQ

Q1. What is the use of OCTREOKAL-50?
It is primarily applied to the treatment of acromegaly and hormone-secreting tumors, and to the management of severe diarrhea and flushing due to tumors.

Q2. Is it applicable in bleeding varices?
Octreotide, yes, is useful in controlling bleeding esophageal varices, typically in combination with endoscopic procedures.

Q3. Is it safe to diabetics?
It should be used with caution since it can influence blood sugar. Regular monitoring of blood glucose should be done.

Q4. In what way is it given?
It is injected by a medical practitioner through subcutaneous injection or intravenous infusion.

Q5. Is there a problem with long-term use?
Yes, there is a risk of developing gallstones or digestive disturbances, with long-term use, and it is important to monitor.

Request a Callback